News Archives - Page 492 of 722

FridaySep 25, 2020 11:48 am

180 Life Sciences Corp. Leading Research into Novel Drug Therapies Expected to Produce First Results of Phase 2b/3 Trial in 2021

Anti-inflammatory therapeutics market to generate revenues of $191.42 billion through 2027 Novel drug therapy for Fibrosis and Anti-TNF trials being conducted by Professor Sir Marc Feldmann, who already developed one of the most commonly used anti-TNF medications, Remicade The number of conditions with chronic inflammation is expected to increase persistently over the next 30 years in the United States. 180 Life Sciences is in the process of being acquired by KBLM Merger Corp. and the acquisition is expected to finalize in Q4 2020 Clinical-stage biotechnology company 180 Life Sciences Corp. is leading the way with research into the world’s most…

FridaySep 25, 2020 10:58 am

The Movie Studio Inc. (MVES) Making Major Moves in Growing Streaming Market

Streaming sites are among businesses that have seen an uptick in sales during worldwide pandemic Content key for companies in streaming space The Movie Studio moving forward in space, expanding content and keeping costs down Not all businesses are struggling through the worldwide pandemic. A recent CompariTech article reported that streaming video is becoming a viable option for a growing number of viewers around the world, resulting in increasing numbers for companies involved in streaming content (https://ibn.fm/wSNni). The Movie Studio (MVES), a vertically integrated motion picture production and distribution company, is looking to become a major player in this star-studded…

ThursdaySep 24, 2020 2:08 pm

Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Inks Major Contract; Skyline Medical Seals STREAMWAY Deal

POAI’s Soluble Biotech announces first substantial contract with pharmaceutical company since acquisition Founder calls contract “major milestone,” validation of move into new facility POAI’s Skyline Medical sells eight proprietary STREAMWAY(R) systems to Virginia-based hospital organization Soluble Biotech, a division of Predictive Oncology (NASDAQ: POAI), has finalized its first substantial contract with a pharmaceutical company since being acquired by POAI earlier this year (https://ibn.fm/gXjd2). Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. The contract calls for Soluble Biotech’s expertise in protein expression and solubility studies. “Our first…

ThursdaySep 24, 2020 12:44 pm

In Wake of Hurricane Laura, Sustainable Green Team Ltd. (SGTM) Plays Pivotal Role in Relief Support

SGTM secures Hurricane Laura recovery work contract for ArborPro of Mississippi Inc. Initial relief efforts will divert trees from landfills to temporary holding sites SGTM transforms natural storm waste into organic environmentally beneficial products As “stewards of the environment”, Sustainable Green Team (OTC: SGTM) takes its role in environmental remediation seriously by providing beneficial solutions for tree and storm waste disposal. In the wake of Hurricane Laura, SGTM rose to the occasion by securing a contract for ArborPro of Mississippi Inc. (APM), one of its strategic partners. The recovery work planned will kickstart SGTM’s process, diverting many destroyed trees from…

ThursdaySep 24, 2020 10:28 am

Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Supply Chain Trading Platform Gives Independent Drugstores a New Lease on Life

Pressing need for efficient drug procurement, delivery as costs rise Trxade platform speeds up delivery, cuts costs Such efficiencies crucial to keeping America’s independent pharmacies alive Around half of 24,000 independent pharmacies have already signed on These days, critics of the U.S. health-care system may be tempering their censure. After all, the sector has proved its worth in the battle against the coronavirus pandemic. Yet some of the fault-finding had merit. The system is bloated and plagued by inefficiencies. Even doctors agree, as a recent report in the “Journal of the American Medical Association” (“JAMA”) indicates (https://ibn.fm/bL7C1). Digital technologies may help…

WednesdaySep 23, 2020 2:33 pm

Kaival Brands Innovations Group Inc. (KAVL) Seeks to Bring Innovative New Offering to Vape Scene

KAVL recently announced the Bidi(TM) Vapor Premarket Tobacco Product Application submission to FDA, a premium recyclable vape pen Application includes 285,000 pages with science-backed evidence that Bidi(TM) Sticks are Appropriate for Protection of Public Health (“APPH”) KAVL and Bidi(TM) Vapor fully support proper regulation of safety manufacturing and marketing of vape products Bidi(TM) Sticks are produced in 11 flavors with 6% nicotine concentration With a focus on growing and incubating innovative products into mature dominant brands, Kaival Brands Innovations Group (OTCQB: KAVL) recently entered into a partnership with Bidi (TM) Vapor, LLC for exclusive global distribution rights for the Bidi(TM)…

WednesdaySep 23, 2020 2:07 pm

GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Trades on OTCQB, Creating Early Opportunity for American Investors

GoldHaven to trade on OTCQB under ticker symbol ATUMF Move provides liquidity in trading of shares, creates opportunity for American investors to participate in Maricunga Gold Belt activity GoldHaven recently entered into agreements to acquire seven gold projects, plans aggressive drill program GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, has announced that it has been accepted for trading on the OTCQB (https://ibn.fm/fB9Z3). The OTCQB exchange is a United States stock market based in New York City and operated by OTC Markets Group. The shares will trade on OTCQB…

WednesdaySep 23, 2020 1:51 pm

United Bid to Liberalize Use of Psilocybin Strengthens

Leading UK scientists, policy group call for rescheduling of psilocybin amid looming mental health crisis Sent to the Home Office with statements of support from leading scientists, paper urges for psilocybin use on a research-only model Cybin Corp. to capitalize on international expansion of psilocybin use as a company active in both research, nonclinical spaces The United Kingdom (“UK”) is joining other countries, including Canada, in a push to facilitate the wider use of psilocybin, a naturally occurring compound found in mushrooms. Focusing on psychedelic and nutraceutical products, Cybin Corp. is poised to leverage the growing global momentum the compound is…

WednesdaySep 23, 2020 12:53 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Mines Investment-building Opportunity for Brain Tumor-Targeting Drug Candidate at Annual Conference

CNS Pharmaceuticals is a clinical-stage biotechnology company developing therapies to combat aggressive cancers of the brain and central nervous system The company will be applying for approval to launch Phase II trials in the first quarter of 2021 for its leading drug candidate, Berubicin, which targets glioblastoma multiforme (“GBM”) brain cancer CNS Pharmaceuticals CEO addressed the company’s achievements and its vision for Berubicin development during the recent 22nd annual Global Investment Conference sponsored by H.C. Wainwright & Co. C. Wainwright is a full-service investment bank focused on capital markets and equity research in market sectors that hinge on industries encompassing…

WednesdaySep 23, 2020 11:45 am

SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Platform Publishes Crucial Insights into US Consumer Trends Amid Pandemic

SRAX’s BIGtoken’s platform allows companies to gain transparent, instant insights from platform’s 16.7+ million subscribers BIGtoken surveyed US user-base in early April and again in August in bid to track changes in US consumer behavior Actionable insights gleaned from survey reveal US citizens’ consumption habits SRAX Inc. (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has recently published the results of a series of surveys carried out by BIGtoken, its proprietary consumer insights platform. BIGtoken enables its platform’s user base of over 16.7 million consumers to both own their data and monetize it in an…

Site Search

Company Search

Category: News